News

Moleculin Biotech, Inc.: Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...
Georgia Today54m
National Bank of Georgia rejects SWIFT disconnection concerns
The National Bank of Georgia (NBG) has stated that there is no justification for disconnecting Georgia’s financial system ...